Monoclonal antibodies targeting the FimH adhesin protect against uropathogenic <i>E. coli</i> UTI
Edward D. B. Lopatto(Washington University in St. Louis), Scott J. Hultgren(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Philippe Azimzadeh(Washington University in St. Louis), Sameer Kumar Malladi(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), Jerome S. Pinkner, Jackson S. Turner(Washington University in St. Louis), Isabella F. Fox(Washington University in St. Louis), Karen Dodson, Jesús Santiago-Borges(Washington University in St. Louis), Andrew L. Kau(Washington University in St. Louis), Denise A. Sanick(Washington University in St. Louis), Shaza Sayed Ahmed(Washington University in St. Louis), Morgan R. Timm(Washington University in St. Louis), Lillian Ortinau(Washington University in St. Louis), Nathaniel C. Gualberto(Washington University in St. Louis)
Cited by 2
Related Papers
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
|Nature Reviews Microbiology|2015|4.1k
Regulation of Intestinal α-Defensin Activation by the Metalloproteinase Matrilysin in Innate Host Defense
|Science|1999|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era
|Cold Spring Harbor Perspectives in Medicine|2013|978